KBL Merger Corp. IV announced the signing of a definitive agreement to acquire 180 Life Sciences Corp. The company announced the appointment of Professor Richard Barker, Larry Gold Md., Shoshana Shendelman PhD., and Donald McGovern Jr., to its Board of Directors, upon completion of the business combination. 180 Life Sciences is led by Dr. James Woody who previously served as the founding CEO of OncoMed Pharmaceuticals, as well as President and General Manager of Roche Bioscience. Dr. Larry Gold, Ph.D., is an internationally recognized scientist, member of the U.S. National Academy of Sciences and biotech entrepreneur who founded NeXagen Inc., which later became NeXstar Pharmaceuticals Inc., and acquired by Gilead Sciences.